Ota Z - Search Results

1

Effects of long-term administration of a combined alpha- and beta-adrenoceptor blocking agent on glucose and lipid metabolisms in patients with non-insulin-dependent diabetes mellitus.

Okada S, Ichiki K, Tanokuchi S, Ishii K, Hamada H, Ota Z. Okada S, et al. Among authors: ota z. J Int Med Res. 1995 Mar-Apr;23(2):106-11. doi: 10.1177/030006059502300203. J Int Med Res. 1995. PMID: 7601292 Clinical Trial.

2

Decreased creatinine clearance which may be observed during prostaglandin E1 therapy: is it reversible with discontinuation of therapy?

Okada S, Miyai Y, Sato K, Higuchi T, Ichiki K, Tanokuchi S, Ishii K, Hamada H, Ota Z. Okada S, et al. Among authors: ota z. J Int Med Res. 1991 Nov-Dec;19(6):493-6. doi: 10.1177/030006059101900610. J Int Med Res. 1991. PMID: 1773910

3

Effect of prostaglandin E1 on renal haemodynamics in a patient with diabetic nephropathy.

Okada S, Ogino Y, Ichiki K, Tanokuchi S, Ishii K, Hamada H, Ota Z, Hiraki Y. Okada S, et al. Among authors: ota z. J Int Med Res. 1991 Nov-Dec;19(6):497-500. doi: 10.1177/030006059101900611. J Int Med Res. 1991. PMID: 1773911

4

Influence of prostaglandin E1 on heavy proteinuria in slightly azotaemic diabetics.

Okada S, Sato K, Higuchi T, Ichiki K, Tanokuchi S, Ishii K, Hamada H, Ota Z. Okada S, et al. Among authors: ota z. J Int Med Res. 1991 Mar-Apr;19(2):171-3. doi: 10.1177/030006059101900212. J Int Med Res. 1991. PMID: 1864454

5

Complement activation pathways associated with islet cell surface antibody (ICSA) derived from child patients with insulin-dependent diabetes mellitus (IDDM).

Okada S, Ichiki K, Sato K, Tanokuchi S, Ishii K, Hamada H, Ota Z. Okada S, et al. Among authors: ota z. Acta Med Okayama. 1991 Jun;45(3):185-6. doi: 10.18926/AMO/32207. Acta Med Okayama. 1991. PMID: 1909828

6

Complement activation via the alternative pathway in a patient with insulin-dependent diabetes mellitus.

Okada S, Ichiki K, Tanokuchi S, Ishii K, Hamada H, Yamamoto H, Ota Z. Okada S, et al. Among authors: ota z. J Int Med Res. 1991 Jul-Aug;19(4):348-50. doi: 10.1177/030006059101900408. J Int Med Res. 1991. PMID: 1916009

7

Does protease inhibitor inhibit complement activation caused by the immune complex associated with islet cell surface antibody?

Okada S, Sato K, Ichiki K, Tanokuchi S, Ishii K, Ota Z, Takeda A. Okada S, et al. Among authors: ota z. J Int Med Res. 1991 May-Jun;19(3):234-6. doi: 10.1177/030006059101900309. J Int Med Res. 1991. PMID: 1936512

8

Clinofibrate therapy raises high-density lipoprotein levels and lowers atherogenic index in diabetes mellitus patients.

Okada S, Miyai Y, Ichiki K, Sato K, Masaki Y, Higuchi T, Ogino Y, Ota Z. Okada S, et al. Among authors: ota z. J Int Med Res. 1989 Nov-Dec;17(6):521-5. doi: 10.1177/030006058901700604. J Int Med Res. 1989. PMID: 2628128

9

Relationship between cardiosympathetic neuropathy and diabetic somatic neuropathy in patients with non-insulin-dependent diabetes mellitus.

Okada S, Ishii K, Tanokuchi S, Ichiki K, Hamada H, Ogino Y, Ota Z, Shimizu M, Hiraki Y. Okada S, et al. Among authors: ota z. J Int Med Res. 1995 Jul-Aug;23(4):228-33. doi: 10.1177/030006059502300402. J Int Med Res. 1995. PMID: 7589765

10

Effect of an alpha-glucosidase inhibitor combined with sulphonylurea treatment on glucose metabolism in patients with non-insulin-dependent diabetes mellitus.

Okada S, Ishii K, Tanokuchi S, Hamada H, Ichiki K, Ota Z. Okada S, et al. Among authors: ota z. J Int Med Res. 1995 Jul-Aug;23(4):279-83. doi: 10.1177/030006059502300408. J Int Med Res. 1995. PMID: 7589771 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

357 results

Search Page

Filters